Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Certara
CERT
$1.27B
| $269K | ﹤0.01% |
16,762
-24,432
| -59% | -$354K |
|
3577
Astronics
ATRO
$3.51B
| $269K | ﹤0.01% |
31,316
+6,862
| +28% | +$50.7K |
|
3578
Domo
DOMO
$184M
| $268K | ﹤0.01% |
18,825
+11,458
| +156% | +$178K |
|
3579
Universal Insurance Holdings
UVE
$1.23B
| $268K | ﹤0.01% |
25,288
+5,121
| +25% | +$52.1K |
|
|
FARO
3580
DELISTED
Faro Technologies
FARO
| $267K | ﹤0.01% |
9,091
+4,234
| +87% | +$126K |
|
3581
Stoneridge
SRI
$210M
| $267K | ﹤0.01% |
12,376
+11,187
| +941% | +$239K |
|
3582
CALL
Norwegian Cruise Line
NCLH
$9.07B
| $266K | ﹤0.01% |
+21,700
| New | +$327K |
|
3583
Theravance Biopharma
TBPH
$874M
| $265K | ﹤0.01% |
23,623
+12,425
| +111% | +$131K |
|
3584
Ecopetrol
EC
$34.1B
| $265K | ﹤0.01% |
+25,281
| New | +$246K |
|
3585
ANI Pharmaceuticals
ANIP
$1.82B
| $263K | ﹤0.01% |
6,546
+2,193
| +50% | +$82.4K |
|
|
PRVB
3586
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $263K | ﹤0.01% |
+24,846
| New | +$200K |
|
3587
Hillman Solutions
HLMN
$1.63B
| $261K | ﹤0.01% |
36,142
+18,863
| +109% | +$142K |
|
3588
ACV Auctions
ACVA
$1.36B
| $260K | ﹤0.01% |
31,642
+26,690
| +539% | +$223K |
|
|
FFIC
3589
DELISTED
Flushing Financial
FFIC
| $260K | ﹤0.01% |
13,402
-12,195
| -48% | -$246K |
|
3590
Peapack-Gladstone Financial
PGC
$821M
| $259K | ﹤0.01% |
6,964
+5,272
| +312% | +$201K |
|
3591
Element Solutions
ESI
$9.18B
| $259K | ﹤0.01% |
14,221
-13,782
| -49% | -$248K |
|
3592
Corsair Gaming
CRSR
$1.15B
| $258K | ﹤0.01% |
19,048
+8,617
| +83% | +$125K |
|
3593
Purple Innovation
PRPL
$39.2M
| $257K | ﹤0.01% |
2,150
+497
| +30% | +$54.4K |
|
3594
Powell Industries
POWL
$8B
| $257K | ﹤0.01% |
21,939
+14,880
| +211% | +$136K |
|
3595
Vera Therapeutics
VERA
$2.31B
| $257K | ﹤0.01% |
13,279
+3,254
| +32% | +$58.9K |
|
3596
Bankwell Financial Group
BWFG
$538M
| $256K | ﹤0.01% |
8,698
+8,459
| +3,539% | +$252K |
|
3597
SiriusPoint
SPNT
$2.75B
| $254K | ﹤0.01% |
43,118
+20,640
| +92% | +$121K |
|
3598
Alto Ingredients
ALTO
$377M
| $252K | ﹤0.01% |
87,649
+68,210
| +351% | +$242K |
|
|
PSAG
3599
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
| $252K | ﹤0.01% |
25,000
| – | – |
|
|
OLPX
3600
DELISTED
Olaplex Holdings
OLPX
| $251K | ﹤0.01% |
48,198
-26,366
| -35% | -$157K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.